Gencurix Inc. (KOSDAQ:229000)

Gencurix Statistics

Total Valuation

Gencurix has a market cap or net worth of KRW 24.76 billion. The enterprise value is 27.36 billion.

Market Cap	24.76B
Enterprise Value	27.36B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Gencurix has 16.12 million shares outstanding.

Current Share Class	16.12M
Shares Outstanding	16.12M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+4.06%
Owned by Insiders (%)	14.55%
Owned by Institutions (%)	n/a
Float	12.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.30
PB Ratio	2.91
P/TBV Ratio	2.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.18
EV / Sales	8.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.13

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.11.

Current Ratio	0.56
Quick Ratio	0.49
Debt / Equity	1.11
Debt / EBITDA	n/a
Debt / FCF	-1.08
Interest Coverage	-14.95

Financial Efficiency

Return on equity (ROE) is -116.64% and return on invested capital (ROIC) is -27.63%.

Return on Equity (ROE)	-116.64%
Return on Assets (ROA)	-23.02%
Return on Invested Capital (ROIC)	-27.63%
Return on Capital Employed (ROCE)	-95.90%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	2.04

Taxes

Income Tax	-143.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.00% in the last 52 weeks. The beta is 0.62, so Gencurix's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-6.00%
50-Day Moving Average	1,556.26
200-Day Moving Average	1,676.81
Relative Strength Index (RSI)	49.22
Average Volume (20 Days)	504,201

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gencurix had revenue of KRW 3.39 billion and -12.55 billion in losses. Loss per share was -877.76.

Revenue	3.39B
Gross Profit	2.11B
Operating Income	-10.86B
Pretax Income	-13.42B
Net Income	-12.55B
EBITDA	-9.41B
EBIT	-10.86B
Loss Per Share	-877.76

Balance Sheet

The company has 4.68 billion in cash and 9.48 billion in debt, giving a net cash position of -4.79 billion or -297.43 per share.

Cash & Cash Equivalents	4.68B
Total Debt	9.48B
Net Cash	-4.79B
Net Cash Per Share	-297.43
Equity (Book Value)	8.51B
Book Value Per Share	701.93
Working Capital	-5.72B

Cash Flow

In the last 12 months, operating cash flow was -8.28 billion and capital expenditures -463.53 million, giving a free cash flow of -8.74 billion.

Operating Cash Flow	-8.28B
Capital Expenditures	-463.53M
Free Cash Flow	-8.74B
FCF Per Share	-542.55

Margins

Gross Margin	62.26%
Operating Margin	-319.97%
Pretax Margin	-395.51%
Profit Margin	n/a
EBITDA Margin	-277.26%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gencurix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.74%
Shareholder Yield	-35.74%
Earnings Yield	-50.69%
FCF Yield	-35.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gencurix has an Altman Z-Score of -4.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.89
Piotroski F-Score	4